Composition
- Active ingredients
- NILOTINIB TARTRATE EQ 95MG BASE
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- NILOTINIB TARTRATE EQ 95MG BASE · TabletThis page
- NILOTINIB TARTRATE EQ 71MG BASE · TabletNDA219293-001 · Prescription
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA219293.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Danziten
- Active substance
- nilotinib tartrate
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Azurity
- Status
- Prescription
- FDA approval
- 7 Nov 2024
- Application
- NDA219293-002